SITA MET 50/500MG TAB

SITA MET 50/500MG combines sitagliptin and metformin HCL in a single tablet for effective blood sugar management. This dual-action formulation helps control type 2 diabetes by enhancing insulin secretion and improving insulin sensitivity. Sitagliptin works by inhibiting DPP-4 enzymes, while metformin reduces glucose production in the liver. Ideal for patients requiring combination therapy to achieve optimal glycemic control. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.